Guru Ownership Trend
Guru Analysis for Royalty Pharma plc (RPRX)
Royalty Pharma plc (RPRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 7 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $459.43 M.
Top institutional holders include Cliff Asness and Pat Dorsey.
Notably, Pat Dorsey has expressed high conviction in this stock, allocating 8.70% of their equity portfolio to it.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $79.75 M net inflow during the quarter.
Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, John Hussman reduced exposure by 66.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Royalty Pharma plc (RPRX)
Major holders include Cliff Asness ($179.65 M), Pat Dorsey ($109.21 M), Renaissance Technologies (RenTech) ($37.94 M). According to the latest reported data, 7 tracked investment managers collectively hold approximately 8.37 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $79.75 M, with 3 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 4 managers trimmed their positions, while 0 fully exited RPRX. The total reported sell value was $16.89 M.
Yes, 1 managers opened new positions in RPRX, and 2 increased their existing holdings. The total reported buy value was $96.63 M.